All terms in HP
| Label | Id | Description |
|---|---|---|
| Aortic elastic fiber fragmentation | HP_0032083 | [Loss and/or fragmentation of elastic fibers of the media of the aorta creating increasingly extended translamellar spaces, with absence of elastic fibers, and increased gaps in elastic fiber lamellae as identified on a stain for elastic fibers.] |
| Translamellar mucoid extracellular matrix accumulation | HP_0032082 | [A type of mucoid extracellular matrix accumulation in which the increase in mucoid extracellular matrix alters the arrangement of the lamellar units to varying degrees.] |
| Mucoid extracellular matrix accumulation | HP_0200146 | [An increase of medial mucoid extracellular matrix creating translamellar and/or intralamellar expansions including extracellular pools as noted on an H&E stain and/or a stain to highlight extracellular matrix material (Movat's pentachrome, Alcian blue, etc.).] |
| Intralamellar mucoid extracellular matrix accumulation | HP_0032081 | [A type of mucoid extracellular matrix accumulation in which the increase in mucoid extracellular matrix does not significantly alter the arrangement of the lamellar units.] |
| disruption of cells of other organism involved in symbiotic interaction | GO_0051818 | [A process in which an organism has a negative effect on the functioning of the second organism's cells, where the two organisms are in a symbiotic interaction.] |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO_0051817 | [The process in which an organism effects a change in the structure or processes of a second organism, where the two organisms are in a symbiotic interaction.] |
| Aortic medial fibrosis | HP_0032089 | [An increase in collagen fibers creating areas of substitutive fibrosis or a widening of intralamellar spaces in the media of the aorta. This can be seen in conjunction with a loss to varying degrees of parallel arrangement of the elastic lamellae (or lamellar units).] |
| Aortic smooth muscle cell disorganization | HP_0032088 | [Nonparallel arrangement/disarray of smooth muscle cells of the aortic media creating focal/multifocal disarray or sometimes nodular aggregates of smooth muscle cells.] |
| Aortic laminar medial collapse | HP_0032087 | [Architecturally, a compaction of aortic medial elastic fibers that creates thinning of the lamellar unit secondary to a band-like smooth muscle cell loss identified using a stain for elastic fibers.] |
| Aortic smooth muscle cell nuclei loss | HP_0032086 | [A region of the aortic media in which smooth muscle cell nuclei, involving multiple lamellae, are not clearly identifiable on an hematoxylin and eosin stain.] |
| Recurrent streptococcal infections | HP_0020096 | [Increased susceptibility to streptococcal infections, as manifested by recurrent episodes of streptococcal infections.] |
| Infection due to encapsulated bacteria | HP_0020097 | [An infection by an encapsulated bacterial agent. Isolates which cause invasive disease are usually surrounded by a polysaccharide capsule, which is a major virulence factor and the key antigen in protective protein-polysaccharide conjugate vaccines.] |
| Herpes encephalitis | HP_0020098 | [Infection of the brain parenchyma with herpes simplex virus, resukting in inflammation of the brain parenchyma with neurologic dysfunction.] |
| Severe norovirus infection | HP_0020099 | [An unusually severe course of infection with Human norovirus, previously known as Norwalk virus. Norovirus, an RNA virus of the family Caliciviridae, is a human enteric pathogen. Norovirus infection-associated illness may also be more prolonged and severe in immunocompromised individuals and may be associated with remarkably persistent viral excretion in some of these individuals.] |
| Post-vaccination polio | HP_0020090 | [Infection with live attenuated polio vaccine following vaccination. This is an extreemely rare event that may indicate immunocompromise.] |
| Infection following live vaccination | HP_0020085 | [An infection resulting from live attenuated vaccines (LAV), that is, a vaccine prepared from living viruses or bacteria that have been weakened under laboratory conditions. LAV vaccines will replicate in a vaccinated individual and produce an immune response but usually cause mild or no disease. are derived from disease-causing pathogens.] |
| Post-vaccination rotavirus infection | HP_0020091 | [Infection with live attenuated rotavirus vaccine following vaccination.] |
| Recurrent deep organ abscess formation | HP_0020093 | [Repeated episodes of the formation of abscesses in organs. An abscess is a circumscribed area of pus or necrotic debris in the parenchyma or an organ.] |
| Prolonged need of intravenous antibiotic therapy | HP_0020095 | [Clinical assessment of a requirement to treat with intravenous antibiotics over an unusually prolonged period of time.] |
| Aplasia of the fallopian tube | HP_0032073 | [Aplasia, that is failure to develop, of the fallopian tube.] |